• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的转化信息学:从大型生物医学数据到微小的可操作改变。

Translational Informatics for Parkinson's Disease: from Big Biomedical Data to Small Actionable Alterations.

机构信息

Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu 610041, China.

Center for Systems Biology, Soochow University, Suzhou 215006, China.

出版信息

Genomics Proteomics Bioinformatics. 2019 Aug;17(4):415-429. doi: 10.1016/j.gpb.2018.10.007. Epub 2019 Nov 28.

DOI:10.1016/j.gpb.2018.10.007
PMID:31786313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6943761/
Abstract

Parkinson's disease (PD) is a common neurological disease in elderly people, and its morbidity and mortality are increasing with the advent of global ageing. The traditional paradigm of moving from small data to big data in biomedical research is shifting toward big data-based identification of small actionable alterations. To highlight the use of big data for precision PD medicine, we review PD big data and informatics for the translation of basic PD research to clinical applications. We emphasize some key findings in clinically actionable changes, such as susceptibility genetic variations for PD risk population screening, biomarkers for the diagnosis and stratification of PD patients, risk factors for PD, and lifestyles for the prevention of PD. The challenges associated with the collection, storage, and modelling of diverse big data for PD precision medicine and healthcare are also summarized. Future perspectives on systems modelling and intelligent medicine for PD monitoring, diagnosis, treatment, and healthcare are discussed in the end.

摘要

帕金森病(PD)是一种常见的老年神经系统退行性疾病,随着全球人口老龄化的到来,其发病率和死亡率呈上升趋势。传统的从小数据到生物医学研究大数据的范式正在向基于大数据的小的可操作改变的识别转变。为了强调大数据在精准 PD 医学中的应用,我们回顾了 PD 大数据和信息学,以将基础 PD 研究转化为临床应用。我们强调了一些具有临床可操作性改变的关键发现,如 PD 风险人群筛查的易感性遗传变异、PD 患者诊断和分层的生物标志物、PD 的风险因素以及预防 PD 的生活方式。还总结了与 PD 精准医学和医疗保健相关的各种大数据的收集、存储和建模所面临的挑战。最后讨论了用于 PD 监测、诊断、治疗和医疗保健的系统建模和智能医学的未来展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/d7e74c9991c2/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/09c9b6dbb7cc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/aea4374e9ae6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/a3e4dd41a0bd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/6b9d5c794245/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/d7e74c9991c2/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/09c9b6dbb7cc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/aea4374e9ae6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/a3e4dd41a0bd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/6b9d5c794245/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bec/6943761/d7e74c9991c2/gr5.jpg

相似文献

1
Translational Informatics for Parkinson's Disease: from Big Biomedical Data to Small Actionable Alterations.帕金森病的转化信息学:从大型生物医学数据到微小的可操作改变。
Genomics Proteomics Bioinformatics. 2019 Aug;17(4):415-429. doi: 10.1016/j.gpb.2018.10.007. Epub 2019 Nov 28.
2
Translational Informatics Connects Real-World Information to Knowledge in an Increasingly Data-Driven World.在一个数据驱动程度日益提高的世界中,转化信息学将现实世界的信息与知识相连接。
Clin Pharmacol Ther. 2020 Apr;107(4):738-741. doi: 10.1002/cpt.1719. Epub 2019 Dec 14.
3
Functional Neuroimaging in the New Era of Big Data.新时代的功能神经影像学:大数据篇
Genomics Proteomics Bioinformatics. 2019 Aug;17(4):393-401. doi: 10.1016/j.gpb.2018.11.005. Epub 2019 Dec 4.
4
Integrative methods for analyzing big data in precision medicine.精准医学中大数据分析的整合方法。
Proteomics. 2016 Mar;16(5):741-58. doi: 10.1002/pmic.201500396.
5
Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease.精准医学在帕金森病中的应用:针对遗传性帕金森病的新兴治疗方法。
J Neurol. 2020 Mar;267(3):860-869. doi: 10.1007/s00415-020-09705-7. Epub 2020 Jan 23.
6
Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.预测性大数据分析:一项使用大规模、复杂、异构、不一致、多源和不完整观测数据对帕金森病的研究。
PLoS One. 2016 Aug 5;11(8):e0157077. doi: 10.1371/journal.pone.0157077. eCollection 2016.
7
The role of pharmacogenomics in the personalization of Parkinson's disease treatment.药物基因组学在帕金森病个体化治疗中的作用。
Pharmacogenomics. 2020 Sep;21(14):1033-1043. doi: 10.2217/pgs-2020-0031. Epub 2020 Sep 7.
8
Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.LRRK2 和 GBA 风险变异帕金森病患者的精准医学——让我们变得更加个体化。
Transl Neurodegener. 2020 Oct 16;9(1):39. doi: 10.1186/s40035-020-00218-x.
9
Role of rodent models in advancing precision medicine for Parkinson's disease.啮齿动物模型在推进帕金森病精准医学中的作用。
Handb Clin Neurol. 2023;193:3-16. doi: 10.1016/B978-0-323-85555-6.00002-3.
10
The potential use of big data in oncology.大数据在肿瘤学中的潜在应用。
Oral Oncol. 2019 Nov;98:8-12. doi: 10.1016/j.oraloncology.2019.09.003. Epub 2019 Sep 12.

引用本文的文献

1
NDDRF 2.0: An update and expansion of risk factor knowledge base for personalized prevention of neurodegenerative diseases.神经退行性疾病个性化预防风险因素知识库2.0:更新与扩展
Alzheimers Dement. 2025 May;21(5):e70282. doi: 10.1002/alz.70282.
2
Deciphering shared molecular dysregulation across Parkinson's disease variants using a multi-modal network-based data integration and analysis.使用基于多模态网络的数据整合与分析来解读帕金森病不同变体之间共享的分子失调情况。
NPJ Parkinsons Dis. 2025 Mar 31;11(1):63. doi: 10.1038/s41531-025-00914-3.
3
How Lifetime Evolution of Parkinson's Disease Could Shape Clinical Trial Design: A Shared Patient-Clinician Viewpoint.

本文引用的文献

1
Relationship between Freezing of Gait and Anxiety in Parkinson's Disease Patients: A Systemic Literature Review.帕金森病患者步态冻结与焦虑之间的关系:一项系统文献综述。
Parkinsons Dis. 2019 Jul 24;2019:6836082. doi: 10.1155/2019/6836082. eCollection 2019.
2
What Is the Best Electrophysiologic Marker of the Outcome of Subthalamic Nucleus Stimulation in Parkinson Disease?帕金森病丘脑底核刺激结果的最佳电生理标志物是什么?
World Neurosurg. 2018 Dec;120:e1217-e1224. doi: 10.1016/j.wneu.2018.09.047. Epub 2018 Sep 18.
3
Frequency of mood and anxiety fluctuations in Parkinson's disease patients with motor fluctuations: A systematic review.
帕金森病的终生演变如何影响临床试验设计:患者与临床医生的共同观点。
Brain Sci. 2024 Apr 3;14(4):358. doi: 10.3390/brainsci14040358.
4
From multi-omics approaches to personalized medicine in myocardial infarction.从多组学方法到心肌梗死的个性化医疗
Front Cardiovasc Med. 2023 Oct 30;10:1250340. doi: 10.3389/fcvm.2023.1250340. eCollection 2023.
5
Challenges and best practices for digital unstructured data enrichment in health research: A systematic narrative review.健康研究中数字非结构化数据充实的挑战与最佳实践:一项系统性叙述性综述
PLOS Digit Health. 2023 Oct 11;2(10):e0000347. doi: 10.1371/journal.pdig.0000347. eCollection 2023 Oct.
6
The evolution of Big Data in neuroscience and neurology.神经科学与神经病学中大数据的发展
J Big Data. 2023;10(1):116. doi: 10.1186/s40537-023-00751-2. Epub 2023 Jul 10.
7
NDDRF: A risk factor knowledgebase for personalized prevention of neurodegenerative diseases.NDDRF:用于个性化预防神经退行性疾病的风险因素知识库。
J Adv Res. 2022 Sep;40:223-231. doi: 10.1016/j.jare.2021.06.015. Epub 2021 Jun 20.
8
Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis.用于癌症微小RNA生物标志物发现的多变量竞争性内源性RNA网络特征分析:一种应用于前列腺癌转移的新型生物信息学模型
Precis Clin Med. 2022 Jan 10;5(1):pbac001. doi: 10.1093/pcmedi/pbac001. eCollection 2022 Mar.
9
The fourth scientific discovery paradigm for precision medicine and healthcare: Challenges ahead.精准医学与医疗保健的第四种科学发现范式:未来的挑战。
Precis Clin Med. 2021 Apr 16;4(2):80-84. doi: 10.1093/pcmedi/pbab007. eCollection 2021 Jun.
10
Translational Informatics for Natural Products as Antidepressant Agents.天然产物作为抗抑郁剂的转化信息学
Front Cell Dev Biol. 2022 Jan 20;9:738838. doi: 10.3389/fcell.2021.738838. eCollection 2021.
帕金森病伴运动波动患者心境和焦虑波动的频率:系统评价。
Mov Disord. 2018 Oct;33(10):1521-1527. doi: 10.1002/mds.27465. Epub 2018 Sep 17.
4
Simulating the Large-Scale Erosion of Genomic Privacy Over Time.随时间模拟大规模基因组隐私侵蚀。
IEEE/ACM Trans Comput Biol Bioinform. 2018 Sep-Oct;15(5):1405-1412. doi: 10.1109/TCBB.2018.2859380. Epub 2018 Jul 24.
5
NDDVD: an integrated and manually curated Neurodegenerative Diseases Variation Database.NDDVD:一个综合的、人工 curated 的神经退行性疾病变异数据库。
Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay018.
6
Clinical features and electrocardiogram parameters in Parkinson's disease.帕金森病的临床特征和心电图参数
Neurol Int. 2017 Dec 11;9(4):7356. doi: 10.4081/ni.2017.7356.
7
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.早期帕金森病临床和生物学指标的纵向变化:帕金森进展标志物倡议队列。
Mov Disord. 2018 May;33(5):771-782. doi: 10.1002/mds.27361. Epub 2018 Mar 23.
8
Genetic risk factors in Parkinson's disease.帕金森病的遗传风险因素。
Cell Tissue Res. 2018 Jul;373(1):9-20. doi: 10.1007/s00441-018-2817-y. Epub 2018 Mar 13.
9
Clinical Markers of Anxiety Subtypes in Parkinson Disease.帕金森病焦虑亚型的临床标志物
J Geriatr Psychiatry Neurol. 2018 Mar;31(2):55-62. doi: 10.1177/0891988718757369. Epub 2018 Mar 11.
10
Cognitive Impairment in Parkinson's Disease Is Reflected with Gradual Decrease of EEG Delta Responses during Auditory Discrimination.帕金森病中的认知障碍通过听觉辨别过程中脑电图δ波反应的逐渐降低得以体现。
Front Psychol. 2018 Feb 21;9:170. doi: 10.3389/fpsyg.2018.00170. eCollection 2018.